Clinical Trial Update: Efficacy of Intradiscal Injection of Autologous BM-MSC in Worker Patients Affected by Chronic LBP Due to Multilevel IDD [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intradiscal injection of autologous bone marrow-derived mesenchymal stem cells for chronic low-back pain due to multilevel intervertebr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intervertebral Disc Degeneration
• Low Back Pain

Drugs mentioned

• Autologous bone marrow-derived mesenchymal stem cells (BM-MSC) for intradiscal injection (bone marrow-derived mesenchymal stem cells)

Snippet

Sponsor: Fondazione Policlinico Universitario Campus Bio-Medico | Conditions: Intervertebral Disc Degeneration, Chronic Low-back Pain | Phase 2 | Status: COMPLETED